Basic statistics.

Slides:



Advertisements
Similar presentations
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia N Engl J Med Mar 11;362(10): Paul W. Ladenson, M.D., Jens D.
Advertisements

Epidemiologic Study Designs Clinical Studies & Objective Medicine
Critical appraisal of research Sarah Lawson
How to assess an abstract
Clinical Epidemiology – the basics
How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
GATE: Graphic Approach To Epidemiology
Reporting drugs and treatments Thomas Abraham JMSC 6090.
PP (Study Design) for 2nd Year
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
Study Designs in Epidemiologic
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
Design and Analysis of Clinical Study 12. Randomized Clinical Trials Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Extension Article by Dr Tim Kenny
Introduction to Critical Appraisal : Quantitative Research
Critical Appraisal for MRCGP Jim McMorran Coventry GP GP trainer Editor GPnotebook (
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Interpreting Basic Statistics
Clinical trial The Way We Make Progress Against Disease Prof. Ashry Gad Mohamed Prof. of Epidemiology College of Medicine & KKUH.
Statistics for Health Care
TREATMENT 1 Evaluation of interventions How best assess treatments /other interventions? RCT (randomised controlled trial)
Critical Appraisal of an Article on Therapy (2). Formulate Clinical Question Patient/ population Intervention Comparison Outcome (s) Women with IBS Alosetron.
Absolute, Relative and Attributable Risks. Outcomes or differences that we are interested in:  Differences in means or proportions  Odds ratio (OR)
 Mean: true average  Median: middle number once ranked  Mode: most repetitive  Range : difference between largest and smallest.
Multiple Choice Questions for discussion
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
EBD for Dental Staff Seminar 2: Core Critical Appraisal Dominic Hurst evidenced.qm.
AETIOLOGY Case control studies (also RCT, cohort and ecological studies)
Lecture 17 (Oct 28,2004)1 Lecture 17: Prevention of bias in RCTs Statistical/analytic issues in RCTs –Measures of effect –Precision/hypothesis testing.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
EVIDENCE BASED MEDICINE Effectiveness of therapy Ross Lawrenson.
Measures of Association
Analyzing Randomized Control Trial: ITT vs. PP vs. AT Proceedings from Journal club….. Vikash.
Evidence Based Medicine & Basic Critical Appraisal
How to Analyze Therapy in the Medical Literature (part 2)
CAT 3 Harm, Causation Maribeth Chitkara, MD Rachel Boykan, MD.
Understanding real research 4. Randomised controlled trials.
Appraising Evidence into our Practice. Objectives Deciding the research result into practice in specific context Interpreting/calculating Number Needed.
Case-control study Chihaya Koriyama August 17 (Lecture 1)
Stats Facts Mark Halloran. Diagnostic Stats Disease present Disease absent TOTALS Test positive aba+b Test negative cdc+d TOTALSa+cb+da+b+c+d.
Measuring associations between exposures and outcomes
Describing the risk of an event and identifying risk factors Caroline Sabin Professor of Medical Statistics and Epidemiology, Research Department of Infection.
Clinical epidemiology
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Compliance Original Study Design Randomised Surgical care Medical care.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
4S: Scandinavian Simvastatin Survival Study
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
بسم الله الرحمن الرحیم.
Making Randomized Clinical Trials Seem Less Random Andrew P.J. Olson, MD Assistant Professor Departments of Medicine and Pediatrics University of Minnesota.
EBM --- Journal Reading Presenter :林禹君 Date : 2005/10/26.
CRITICAL APPARAISAL OF A PAPER ON THERAPY 421 CORSE EVIDENCE BASED MEDICINE (EBM)
Biostatistics Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016.
Case control & cohort studies
Article Title Resident Name, MD SVCH6/13/2016 Journal Club.
What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
EBM R1張舜凱.
HelpDesk Answers Synthesizing the Evidence
Study Designs Group Work
Question 1 A new ‘Super test’ claims to have a superb capability to diagnose disease X. Its sensitivity is 99% and specificity is 90%. Which of the following.
Interpreting Basic Statistics
Measurements of Risk & Association …
Measures of risk and association
How to assess an abstract
PICO model for developing EBM questions
Research Techniques Made Simple: Interpreting Measures of Association in Clinical Research Michelle Roberts PhD,1,2 Sepideh Ashrafzadeh,1,2 Maryam Asgari.
Basic statistics.
Presentation transcript:

Basic statistics

EBM SKILLS - STATISTICS CHANCE - p = 1 in 20 (0.05). > 1 in 20 (0.051) = not significant < 1 in 20 (0.049) = statistically significant CONFIDENCE INTERVALS what is the range of values between which we could be 95% certain that this result would lie if this intervention was applied to the general population

EBM SKILLS - A BASIC INTRODUCTION CHANCE, BIAS, CONFOUNDING VARIABLES

TYPES OF STUDY - HYPOTHESIS FORMING CASE REPORTS / CASE SERIES CROSS SECTIONAL / PREVALENCE STUDIES measure personal factors & disease states - hypothesis FORMING - cannot indicate cause & effect CORRELATIONAL / ECOLOGICAL / GEOGRAPHIC STUDIES. prevalence &/or incidence measurement in one population c/w another pop.

TYPES OF STUDY - HYPOTHESIS TESTING CASE CONTROL STUDIES

CASE CONTROL EXAMPLE -SMOKING & LUNG CANCER DISEASE Cases Controls EXPOSURE Yes a b EXPOSURE No c d Odds Ratio = ad/bc (1 = no association, > 1 = possible association, < 1 = protective effect) (lung cancer) EXPOSURE Yes 56 230 (smoking) No 7 246 The odds ratio would therefore be 56 x 246 = 13776 = 8.6. 7 x 230 1610

TYPES OF STUDY - HYPOTHESIS TESTING COHORT STUDIES

This is expressed as a divided by c . COHORT STUDIES OUTCOME Yes No Exposed a b Not exposed c d Attributable risk (absolute risk or risk difference) "What is the incidence of disease attributable to exposure" Answer = a - c. Relative risk "How many times are exposed persons more likely to develop the disease, relative to non-exposed persons?" i.e. the incidence in the exposed divided by the incidence in the non-exposed. This is expressed as a divided by c . a+b c+d

Exposed ( on oral contraceptive ) 41 9996 COHORT STUDY EXAMPLE Deep vein thromboses (DVT) in oral contraceptive users. (Hypothetical results). OUTCOME (DVT) Yes No Exposed ( on oral contraceptive ) 41 9996 Not exposed (not on o.c.) 7 10009 These results would give an attributable risk of 34 and a relative risk of 6 - significantly large enough numbers to indicate the possibility of a real association between exposure and outcome. However, the possibility of biases very often arises.

RANDOMISED CONTROLLED TRIALS

RANDOMISED CONTROLLED TRIALS OUTCOME Yes No Comparison intervention a b Experimental intervention c d Relative risk reduction: “ How many fewer patients will get the outcome measured if they get active treatment versus comparison intervention” a /a+b - c/c+d a/a+b Absolute risk reduction: “What is the size of this effect in the population” a/a+b - c/c+d

RCT EXAMPLE - 4S STUDY STABLE ANGINA OR MYOCARDIAL INFARCTION MORE THAN 6 MONTHS PREVIOUSLY SERUM CHOLESTEROL > 6.2mmol/l EXCLUDED PATIENTS WITH ARYHTHMIAS AND HEART FAILURE ALL PATIENTS GIVEN 8 WEEKS OF DIETARY THERAPY IF CHOLESTEROL STILL RAISED (>5.5) RANDOMISED TO RECEIVE SIMVASTATIN (20mg > 40mg) OR PLACEBO OUTCOME DEATH OR MYOCARDIAL INFARCTION (LENGTH OF TREATMENT 5.4 YEARS ) WERE THE OUTCOMES

1/ARR = NUMBER NEEDED TO TREAT. RCT EXAMPLE - 4S STUDY OUTCOME (death) Yes No Comparison intervention (placebo) 256 1967 2223 Experimental intervention (simvastatin) 182 2039 2221 The ARR is (256/2223) - (182/2221) = 0.115 - 0.082 = 0.033. The RRR is 0.033/0.115 = 0.29 or expressed as a percentage 29%. 1/ARR = NUMBER NEEDED TO TREAT. 1/0.033 = 30. i.e. if we treat 30 patients with IHD with simvastatin as per 4S study, in 5.4 years we will have prevented 1 death.

NNT EXAMPLES Intervention Outcome NNT

Why are RCTs the “gold standard” Breast cancer mortality in studies of screening with mammography; women aged 50 and over (55 in Malmo study, 45 in UK)

SCREENING - WILSON & JUNGEN (WHO, 1968) IS THE DISORDER COMMON / IMPORTANT ARE THERE TREATMENTS FOR THE DISORDER IS THERE A KNOWN NATURAL HISTORY & “WINDOW OF OPPORTUNITY” WHERE SCREENING CAN DETECT DISEASE EARLY WITH IMPROVED CHANCE OF CURE IS THE TEST ACCEPTABLE TO PATIENTS SENSITIVE AND SPECIFIC GENERALISABLE CHEAP / COST EFFECTIVE APPLY TO GROUP AT HIGH RISK

DISEASE PRESENT ABSENT SCREENING TEST POSITIVE A B NEGATIVE C D Sensitivity = a/a+c; Specificity = d/b+d; positive predicitive value = a/a+b; negative predicitve value = d/c+d.

Value of exercise ECG in coronary artery stenosis DISEASE PRESENT ABSENT TEST POSITIVE 137 11 NEGATIVE 90 112 Sensitivity = a/a+c = 60%; Specificity = d/b+d = 91%; positive predicitive value = a/a+b = 93%; negative predicitve value = d/c+d = 55%.

Sensitivities and Specificities for different tests Alcohol dependency or abuse (as defined by extensive investigations in medical and orthopaedic in patients) SENS SPEC GGT 54% 76% MCV 63% 64% LFTs 37% 81% “Yes” to 1 or > of CAGE ?s 85% 81% “Yes” to 3 or > of CAGE ?s 51% 100%

MAKING SENSE OF THE EVIDENCE - ARE THESE RESULTS VALID - i. e MAKING SENSE OF THE EVIDENCE - ARE THESE RESULTS VALID - i.e. should I believe them? Randomised (where appropriate)? Drop outs and withdrawals? Followup complete? Analysed in the groups to which randomised?- “Intention to treat”.

MAKING SENSE OF THE EVIDENCE- ARE THESE RESULTS USEFUL. - i. e MAKING SENSE OF THE EVIDENCE- ARE THESE RESULTS USEFUL?- i.e. should I be impressed by them, are they relevant to my patients (GENERALISABLE) How large was the treatment effect? How precise was the estimate of treatment effect Were all important clinical outcomes considered? Do benefits outweigh risks?